Just 90 serious adverse reactions: rashes, swelling, numbness among the most common side effects and nobody (not a single person has died) after 2 million Covid vaccine shots in Saskatchewan. The majority of shots given out in Saskatchewan have been Pfizer and they account for the majority of adverse reactions. However, as a percentage of doses administered, the AstraZeneca shots were more than three times as likely to be linked to problems. ---------- After 2M COVID-19 vaccines, 90 'serious' adverse reactions reported: Sask. Health Rashes, swelling, numbness among the most common side effects CBC News ยท Posted: Jan 22, 2022 4:30 PM CT | Last Updated: 2 hours ago The Saskatchewan government has received reports of 1,155 reports of people experiencing adverse effects from vaccinations. That's 0.004 per cent of all shots given out. (Gerald Herbert/The Associated Press) The Saskatchewan government says since COVID-19 vaccinations started in late 2020, there have been 90 cases of people suffering serious reactions. That includes people who have life-threatening conditions, are hospitalized or have a hospital stay extended. There is no record of anyone dying from a COVID-19 vaccination, according to data published online by the province. Serious reactions account for 0.004 per cent of the 2,234,447 shots given out. With the more minor complaints added in, a total of 1,155 adverse effects have been reported to the ministry of health. The most common side effects include rashes, swelling, numbness and injection site reactions. Sask.'s top doctor says COVID hospital numbers could go up to 500 or more As Sask. reports record high test positivity, expert says we may no longer understand COVID spread The majority of shots given out in Saskatchewan have been Pfizer and they account for the majority of adverse reactions. However, as a percentage of doses administered, the AstraZeneca shots were more than three times as likely to be linked to problems. Not every adverse reaction gets reported. For example, under its guidance to health-care workers, the province says it's not necessary for the system to report people with sore arms, as those symptoms go away in a few days. https://www.cbc.ca/news/canada/saskatchewan/adverse-reactions-from-covid-19-vaccinations-1.6324468 ---------- wrbtrader
In Australia prior to and at the time I got vaccinated about 3 months ago, AstraZeneca was the preferred and only vaccine available for the majority of the population, plus it is manufactured in Australia. These days it is all but phased out, manufactured mainly for export only. I was basically forced to take AZ, there was no options available.
As stated many times here at the forum... I had a complete physical plus blood chemistry work prior to vaccination to determine if I was suitable for vaccination. My Doctor discover I was not suitable for AstraZeneca nor J&J vaccines due to allergies to a few of the ingredients but I was suitable for Moderna. I'm now fully vaccinated with Moderna. Yet, AstraZeneca had the most vaccinations in my area...I think. Also, J&J was the least available in my area but more available in other areas of Canada. wrbtrader
I went to my GP and requested information on if they could find a source other than AZ and they said "no". For the older generation, either go AZ or go without at the time, different now.
I've been reading stories online that many people have been traveling to other countries to get vaccinated with a specific vaccine that was not available in the country they were living in. That would then imply those that weren't able to travel were shit out of luck as in they needed to wait for the vaccine they wanted to become available in their area. wrbtrader
Correct (a) the borders locked down, flights highly curtailed, if not vaccinated even less chance of travel. (b) At the time the Australian govn. were not even hinting there would be substitutes in the future. I was holding off vaccinating in the hope of an alternative to AZ but there was not one clue of them changing the status quo. So weighing up options; no vaccine and chance of serious infection versus take AZ and low risk of blood clotting.
Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine https://www.cnn.com/2022/01/25/health/pfizer-biontech-omicron-vaccine-trial/index.html Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday. The study will evaluate the vaccine for safety, tolerability and the level of immune response, as both a primary series and a booster dose, in up to 1,420 healthy adults ages 18 to 55. The study is broken up into three groups: Participants in the first cohort have received two doses of the current Pfizer Covid-19 vaccine at least 90 to 180 days before the study. They will receive one or two doses of the Omicron-specific vaccine. Participants in the second cohort have received three doses of the current Pfizer Covid-19 vaccine at least 90 to 180 days prior to the study. They will receive one dose of the current Pfizer Covid-19 vaccine or the Omicron-specific vaccine. Participants in the third cohort have not received any Covid-19 vaccine. They will receive three doses of the Omicron-specific vaccine. The Omicron-specific vaccine will be administered as a 30-microgram dose, the same as the current vaccine. "While current research and real-world data show that boosters continue to provide a high level of protection against severe disease and hospitalization with Omicron, we recognize the need to be prepared in the event this protection wanes over time and to potentially help address Omicron and new variants in the future," Pfizer Senior Vice President and Head of Vaccine Research and Development Kathrin Jansen said in the release. Pfizer CEO Albert Bourla said last month that if a new vaccine is needed for the Omicron coronavirus variant, the company will have one in March. However, a Pfizer spokesperson confirmed that the company has already begun to manufacture this vaccine. "In the wake of Omicron, we are proactively investigating and manufacturing at risk an Omicron-based vaccine should it be needed, but we of course need to have results and discussions with health authorities as well as approvals before it would be deployed," the spokesperson told CNN. Expected vaccine production will not be affected if the companies need to pivot to the new vaccine, they said. "The companies have previously announced that they expect to produce four billion doses of the Pfizer-BioNTech COVID-19 Vaccine in 2022, and this capacity is not expected to change if an adapted vaccine is required." However, the companies also emphasized that people who have received booster doses of the current vaccine "maintain a high level of protection against Omicron, particularly against severe disease and hospitalizations." A new preprint lab study suggests that antibodies against the Omicron coronavirus variant remain robust four months after a third dose of the Pfizer/BioNTech vaccine. "Additional real world effectiveness data and laboratory investigations will further inform the duration of protection, potential need for an additional dose at a later time, and whether an Omicron modified vaccine is required," said the study from researchers at the University of Texas Medical Branch, Pfizer and BioNTech.
The Covid vaccines do not affect fertility, unlike dying, which negatively impacts your chances of procreating. COVID-19 vaccines do not affect fertility for women or men, study finds https://abc7.com/covid-19-fertility-vaccine-pregnant-women/11507286/